Knowledge and attitudes regarding preventative HIV vaccine clinical trials in Italy: results of a national survey.
We carried out a telephone survey to assess willingness to participate in HIV vaccine trials. The survey was conducted by interviewing randomly selected callers to the Italian National AIDS Help line. The questionnaire consisted of four sections: demographic information, knowledge about HIV vaccines and vaccines in general, factors related to participation in HIV vaccine trials, and acceptability of a future HIV vaccine. Over 50% of the sample had adequate knowledge about HIV and vaccines. Among the individuals interviewed, 37% would volunteer for a vaccine trial; those reporting high-risk behaviours were more likely to volunteer. Of the participants, 83% would agree to be vaccinated with a highly effective vaccine, and 92% would pay for the vaccine. Although the limits of telephone surveys should not be neglected, the results of this survey are encouraging.
Starace
F
F
Consultation Psychiatry & Behavioural Epidemiology Service, Cotugno Hospital, Naples, Italy. fabrizio.starace@tin.it
Wagner
T M
TM
Luzi
A M
AM
Cafaro
L
L
Gallo
P
P
Rezza
G
G
D016915:AIDS Vaccines / Q000627:therapeutic use*; D000293:Adolescent; D000328:Adult; D002986:Clinical Trials as Topic; D003430:Cross-Sectional Studies; D005260:Female; D015658:HIV Infections / Q000517:prevention & control* / Q000523:psychology; D018023:HIV Seronegativity; D007722:Health Knowledge, Attitudes, Practice; D006306:Health Surveys; D006801:Humans; D007558:Italy; D008297:Male; D008875:Middle Aged; D010342:Patient Acceptance of Health Care
D016915:AIDS Vaccines